what is the dose for microdosing semaglutide GLPs: Hype, Hope & to Know Before You Start Microdose GLP-1 — Zera Health
Description
7,10 Subcutaneous semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist approved for the treatment of type 2 diabetes at doses of 1.0 mg or less once weekly
Virtual Provider Appointments: Our weight loss program in Johnstown, New York facilitates virtual appointments with physicians and licensed providers, eliminating the need for office visits
The highest dose studied in Phase 2, producing up to 24.2% average weight loss at 48 weeks
Recalculate syringe units for the new dose
